After biotech stocks staged a rebound last year, a cash-strapped developer of eye drugs has joined the queue of IPO hopefuls ...

ImmunityBio, Inc. (NASDAQ: IBRX), today announced that it will host a live conference call at 1:30 p.m. Pacific Time on Tuesday, March 3, 2026, to provide a business update, including progress across ...

An integrin mutation impairs skin T cell migration, enabling HPV proliferation that causes warts and lesions in a rare genetic dermatological condition.

The house where Will Self lives on a quiet street in south London is early Edwardian, and it is furnished to match. There are ...

Jana Batson was diagnosed with Hodgkin lymphoma after she insisted upon having a swollen lymph node examined. In addition to ...

New presentations for tildrakizumab-asmn explore real-world use in U.S. patients using Medicare New data specific to patients ...

The field of bovine immunology has made significant strides in understanding the biology and function of T cells, which are crucial players in shaping ...

Dr. Nikolche Gjorevski, Roche Pharma Research and Early Development, will lecture on Engineering Inflammation on February 24, from 11.00-12.00 in DDW-M2.01.

Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales ...

Tech tycoons, podcast bros and Hollywood stars are all piling money into full-body scans, which deploy AI in the hope of catching everything from high cholesterol to cancer. Is this the first step to ...

INSTI, two-drug regimen to demonstrate non-inferiority and a similar safety profile at Week 48 to BIC/FTC/TAF in adults living with HIV-1 who had not previously received antiretroviral ...

Functional nutrition’s HIDDEN message is clear: The body is an interconnected whole, and chronic conditions demand a holistic ...